Elder Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Academic Medical Center, Amsterdam
Familial hypobetalipoproteinemia patients have decreased CV risk
October 26th, 2005
Researchers have investigated hepatic and cardiovascular consequences of familial hypobetalipoproteinemia. Investigators in the Netherlands report, "Individuals with familial hypobetalipoproteinemia (FHBL) have been reported to be prone to fatty liver disease (FLD). Conversely, the profound reduction of low-density lipoprotein (LDL) cholesterol in this disorder might decrease cardiovascular risk." R.R. Sankatsing and colleagues of the Academic Medical Center in Amsterdam wrote, "In [our] study, we assessed hepatic steatosis as well as noninvasive surrogate markers for cardiovascular disease (CVD) in subjects with FHBL and in matched controls. Hepatic...
Source: Elder Law Weekly (2005-10-26)
|
